Mesoblast (MESO) Enterprise Value (2017 - 2025)

Mesoblast's Enterprise Value history spans 7 years, with the latest figure at -$71.3 million for Q2 2023.

  • For Q2 2023, Enterprise Value fell 17.98% year-over-year to -$71.3 million; the TTM value through Jun 2023 reached -$71.3 million, down 17.98%, while the annual FY2024 figure was -$63.0 million, 11.66% up from the prior year.
  • Enterprise Value for Q2 2023 was -$71.3 million at Mesoblast, down from -$60.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$50.4 million in Q2 2019 and bottomed at -$136.9 million in Q2 2021.
  • The 5-year median for Enterprise Value is -$71.3 million (2023), against an average of -$89.7 million.
  • The largest annual shift saw Enterprise Value crashed 156.47% in 2020 before it surged 55.84% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$50.4 million in 2019, then crashed by 156.47% to -$129.3 million in 2020, then dropped by 5.84% to -$136.9 million in 2021, then soared by 55.84% to -$60.4 million in 2022, then dropped by 17.98% to -$71.3 million in 2023.
  • Per Business Quant, the three most recent readings for MESO's Enterprise Value are -$71.3 million (Q2 2023), -$60.4 million (Q2 2022), and -$136.9 million (Q2 2021).